This month PLoS Medicine publishes a Debate that offers three unique perspectives on this question: Sofia Gruskin and Zyde Raad from the Harvard School of Public Health say more assessment is needed of such responsibilities; Geralyn Ritter, Vice President of Global Public Policy and Corporate Responsibility at Merck & Co. argues that multiple stakeholders could do more to help States deliver the right to health; and Paul Hunt and Rajat Khosla introduce Mr. Hunt's work as the UN Special Rapporteur on the right to the highest attainable standard of health (2002-2008), regarding the human rights responsibilities of pharmaceutical companies and access to medicines. In their accompanying Editorial, the PLoS Medicine Editors argue that drug companies should be held much more accountable for their human rights responsibilities.
Image Credit: cosmo flash (at flickr.com)
Editorial
Drug Companies Should Be Held More Accountable for Their Human Rights Responsibilities
PLOS Medicine: published September 28, 2010 | https://doi.org/10.1371/journal.pmed.1000344
The PLoS Medicine Debates
Are Drug Companies Living Up to Their Human Rights Responsibilities? Moving Toward Assessment
PLOS Medicine: published September 28, 2010 | https://doi.org/10.1371/journal.pmed.1000310
Are Drug Companies Living Up to Their Human Rights Responsibilities? The Merck Perspective
PLOS Medicine: published September 28, 2010 | https://doi.org/10.1371/journal.pmed.1000343
Are Drug Companies Living Up to Their Human Rights Responsibilities? The Perspective of the Former United Nations Special Rapporteur (2002-2008)
PLOS Medicine: published September 28, 2010 | https://doi.org/10.1371/journal.pmed.1000330
Perspective
Radiodiagnostic Imaging in Pregnancy and the Risk of Childhood Malignancy: Raising the Bar
PLOS Medicine: published September 7, 2010 | https://doi.org/10.1371/journal.pmed.1000338
Related Articles
Health in Action
AIDS Vaccine for Asia Network (AVAN): Expanding the Regional Role in Developing HIV Vaccines
PLOS Medicine: published September 21, 2010 | https://doi.org/10.1371/journal.pmed.1000331
Policy Forums
Examining the “Urban Advantage” in Maternal Health Care in Developing Countries
PLOS Medicine: published September 14, 2010 | https://doi.org/10.1371/journal.pmed.1000327
Does It Matter Who Writes Medical News Stories?
PLOS Medicine: published September 14, 2010 | https://doi.org/10.1371/journal.pmed.1000323
Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up?
PLOS Medicine: published September 21, 2010 | https://doi.org/10.1371/journal.pmed.1000326
The Haunting of Medical Journals: How Ghostwriting Sold “HRT”
PLOS Medicine: published September 7, 2010 | https://doi.org/10.1371/journal.pmed.1000335
Research Articles
Cost-Effectiveness of Pooled Nucleic Acid Amplification Testing for Acute HIV Infection after Third-Generation HIV Antibody Screening and Rapid Testing in the United States: A Comparison of Three Public Health Settings
PLOS Medicine: published September 28, 2010 | https://doi.org/10.1371/journal.pmed.1000342
Community Case Management of Fever Due to Malaria and Pneumonia in Children Under Five in Zambia: A Cluster Randomized Controlled Trial
PLOS Medicine: published September 21, 2010 | https://doi.org/10.1371/journal.pmed.1000340
Combined Impact of Lifestyle-Related Factors on Total and Cause-Specific Mortality among Chinese Women: Prospective Cohort Study
PLOS Medicine: published September 14, 2010 | https://doi.org/10.1371/journal.pmed.1000339
Effectiveness of Chest Physiotherapy in Infants Hospitalized with Acute Bronchiolitis: A Multicenter, Randomized, Controlled Trial
PLOS Medicine: published September 28, 2010 | https://doi.org/10.1371/journal.pmed.1000345
Major Radiodiagnostic Imaging in Pregnancy and the Risk of Childhood Malignancy: A Population-Based Cohort Study in Ontario
PLOS Medicine: published September 7, 2010 | https://doi.org/10.1371/journal.pmed.1000337
Related Articles
Persistence with Statins and Onset of Rheumatoid Arthritis: A Population-Based Cohort Study
PLOS Medicine: published September 7, 2010 | https://doi.org/10.1371/journal.pmed.1000336
A Genetic Association Study of Serum Acute-Phase C-Reactive Protein Levels in Rheumatoid Arthritis: Implications for Clinical Interpretation
PLOS Medicine: published September 21, 2010 | https://doi.org/10.1371/journal.pmed.1000341